Orlando Health, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Employees
- -
- Market Cap
- -
- Website
- http://www.orlandohealth.com
Efficacy of Continuous Infusion Ropivacaine Interscalene Blocks
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-06-04
- Last Posted Date
- 2020-12-22
- Lead Sponsor
- Orlando Health, Inc.
- Target Recruit Count
- 51
- Registration Number
- NCT02462382
- Locations
- 🇺🇸
Orlando Orthopaedic Center, Orlando, Florida, United States
Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation
Phase 1
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2014-06-09
- Last Posted Date
- 2015-04-28
- Lead Sponsor
- Orlando Health, Inc.
- Registration Number
- NCT02159248
- Locations
- 🇺🇸
UF Health Cancer Center at Orlando Health, Orlando, Florida, United States
Ceftaroline in the Treatment of Bone and Joint Infections
- First Posted Date
- 2013-12-09
- Last Posted Date
- 2014-08-07
- Lead Sponsor
- Orlando Health, Inc.
- Registration Number
- NCT02005068
- Locations
- 🇺🇸
Orlando Regional Medical Center, Orlando, Florida, United States
Percutaneous Catheter Decompression in the Treatment of Elevated Intra-abdominal Pressure
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-10-29
- Last Posted Date
- 2010-10-29
- Lead Sponsor
- Orlando Regional Medical Center
- Target Recruit Count
- 62
- Registration Number
- NCT01230255
- Locations
- 🇺🇸
Orlando Regional Medical Center, Orlando, Florida, United States
Post-Op Rotator Cuff Pain Study With Subacromial Bupivacaine Infusion
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-05-19
- Last Posted Date
- 2014-11-07
- Lead Sponsor
- Orlando Health, Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT01126593
- Locations
- 🇺🇸
Orlando Orthopaedic Center, Orlando, Florida, United States
Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
Completed
- Conditions
- First Posted Date
- 2006-07-25
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Orlando Health, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT00356018
- Locations
- 🇺🇸
Orlando Regional Lucerne Hospital, Orlando, Florida, United States
MRSA Colonization in Peripartum Women and Their Offspring
Completed
- Conditions
- First Posted Date
- 2006-06-13
- Last Posted Date
- 2006-06-13
- Lead Sponsor
- Orlando Regional Medical Center
- Target Recruit Count
- 600
- Registration Number
- NCT00336427
© Copyright 2024. All Rights Reserved by MedPath